Authors:
Gov, Y
Bitler, A
Dell'Acqua, G
Torres, JV
Balaban, N
Citation: Y. Gov et al., RNAIII inhibiting peptide (RIP), a global inhibitor of Staphylococcus aureus pathogenesis: structure and function analysis, PEPTIDES, 22(10), 2001, pp. 1609-1620
Authors:
Hel, Z
Nacsa, J
Kelsall, B
Tsai, WP
Letvin, N
Parks, RW
Tryniszewska, E
Picker, L
Lewis, MG
Edghill-Smith, Y
Moniuszko, M
Pal, R
Stevceva, L
Altman, JD
Allen, TM
Watkins, D
Torres, JV
Berzofsky, JA
Belyakov, IM
Strober, W
Franchini, G
Citation: Z. Hel et al., Impairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251-and simian-human immunodeficiency virus KU2-infected macaques, J VIROLOGY, 75(23), 2001, pp. 11483-11495
Citation: Se. Dunn et al., Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase, CANCER RES, 61(4), 2001, pp. 1367-1374
Authors:
Carlos, MP
Anderson, DE
Gardner, MB
Torres, JV
Citation: Mp. Carlos et al., Immunogenicity of a vaccine preparation representing the variable regions of the HIV type 1 envelope glycoprotein, AIDS RES H, 16(2), 2000, pp. 153-161
Authors:
Balaban, N
Collins, LV
Cullor, JS
Hume, EB
Medina-Acosta, E
da Motta, OV
O'Callaghan, R
Rossitto, PV
Shirtliff, ME
da Silveira, LS
Tarkowski, A
Torres, JV
Citation: N. Balaban et al., Prevention of diseases caused by Staphylococcus aureus using the peptide RIP, PEPTIDES, 21(9), 2000, pp. 1301-1311
Citation: Je. Leestma et Jv. Torres, Unappreciated agenesis of cerebellum in an adult case report of a 38-year-old man, AM J FOREN, 21(2), 2000, pp. 155-161
Authors:
Leung, NJ
Aldovini, A
Young, R
Jarvis, MA
Smith, JM
Meyer, D
Anderson, DE
Carlos, MP
Gardner, MB
Torres, JV
Citation: Nj. Leung et al., The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins, VIROLOGY, 268(1), 2000, pp. 94-103
Authors:
Munoz, JF
Salmen, S
Berrueta, LR
Carlos, MP
Torres, JV
Citation: Jf. Munoz et al., Effect of plasma human immunodeficiency virus type 1 RNA levels on neutrophil oxidative burst - Reply, J INFEC DIS, 181(3), 2000, pp. 1215-1216
Authors:
Carlos, MP
Yamamura, Y
Diaz-Mitoma, F
Torres, JV
Citation: Mp. Carlos et al., Antibodies from HIV-positive and AIDS patients bind to an HIV envelope multivalent vaccine, J ACQ IMM D, 22(4), 1999, pp. 317-324
Citation: D. Meyer et Jv. Torres, Induction of cytotoxic and helper T cell responses by modified simian immunodeficiency virus hypervariable epitope constructs, VIRAL IMMUN, 12(2), 1999, pp. 117-129
Citation: De. Anderson et Jv. Torres, Simian retrovirus receptor and neutralization mechanism by antibodies to the envelope glycoprotein, VIRAL IMMUN, 12(1), 1999, pp. 47-56
Citation: D. Meyer et Jv. Torres, Hypervariable epitope construct: a synthetic immunogen that overcomes MHC restriction of antigen presentation, MOL IMMUNOL, 36(10), 1999, pp. 631-637
Authors:
Vu, HM
Myers, D
de Lorimier, R
Matthews, TJ
Moody, MA
Heinly, C
Torres, JV
Haynes, BF
Spicer, L
Citation: Hm. Vu et al., Nuclear magnetic resonance analysis of solution conformations in C4-V3 hybrid peptides derived from human immunodeficiency virus (HIV) type 1 gp120: Relation to specificity of peptide-induced anti-HIV neutralizing antibodies, J VIROLOGY, 73(1), 1999, pp. 746-750
Authors:
Munoz, JF
Salmen, S
Berrueta, LR
Carlos, MP
Cova, JA
Donis, JH
Hernandez, MR
Torres, JV
Citation: Jf. Munoz et al., Effect of human immunodeficiency virus type 1 on intracellular activation and superoxide production by neutrophils, J INFEC DIS, 180(1), 1999, pp. 206-210